|Day Low/High||23.96 / 25.27|
|52 Wk Low/High||16.51 / 32.25|
I hope we get a decent size market decline so I can add to some stakes in what I think are already undervalued biotech holdings.
Investors in Flexion Therapeutics, Inc. saw new options begin trading this week, for the March 16th expiration.
Investors in Flexion Therapeutics, Inc. saw new options begin trading this week, for the August 2018 expiration.
The most recent short interest data was recently released for the 11/15/2017 settlement date, and Flexion Therapeutics, Inc. is one of the most shorted stocks of the Russell 3000, based on 9.98 "days to cover" versus the median component at 4.67.
The indices are hitting highs as the market shrugs off yesterday's rotation.
I'm looking for some new entries in less-speculative names, but many stocks need a rest at this point.
The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 1,619,401 share increase in total short interest for Flexion Therapeutics, Inc. , to 9,903,318, an increase of 19.55% since 10/13/2017.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
I'm always excited about the potential for new trades when we have selling like this.
The housing market will continue to improve over the next few years due to pent up demand.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.